• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿(HAE)成年和青少年患者群体中血管性水肿生活质量问卷(AE-QoL)的内容效度验证。

Content validation of the Angioedema Quality of Life Questionnaire (AE-QoL) in a population of adult and adolescent patients with hereditary angioedema (HAE).

作者信息

Broderick Lynne, Foster April, Waldman Laura Tesler, Jacobs K D, Bordone Laura, Yarlas Aaron

机构信息

QualityMetric, an IQVIA business, 1301 Atwood Avenue, Suite 216E, Johnston, RI, 02919, USA.

Ionis Pharmaceuticals, Inc, 2855 Gazelle Court, Carlsbad, CA, 92010, USA.

出版信息

J Patient Rep Outcomes. 2025 Apr 12;9(1):42. doi: 10.1186/s41687-025-00876-3.

DOI:10.1186/s41687-025-00876-3
PMID:40220084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11993509/
Abstract

BACKGROUND

There is a lack of clear evidence pointing to a fit-for-purpose instrument to measure impacts on health-related quality of life (HRQoL) in adult and adolescent patients with hereditary angioedema (HAE). The purpose of this study was to determine whether the Angioedema Quality of Life Questionnaire (AE-QoL) is content valid and appropriate for capturing the impact of HAE attacks on HRQoL in both adults and adolescents with HAE.

METHODOLOGY

This study used one-on-one, audio-recorded, cognitive debriefing interviews employing think-aloud and verbal probing approaches to evaluate the relevance, comprehensibility, and comprehensiveness of the AE-QoL in this patient population. All data were quality checked then coded and analyzed using inductive and deductive approaches.

RESULTS

This study included 10 adolescents and 12 adults with HAE in the United States. Overall, participants had positive impressions of the AE-QoL, finding the length and recall period appropriate, and the response options clear and easy to understand. Some reported minor concerns with the instructions, but none that prevented them from completing the instrument. Participants found the instrument relevant to their experiences with HAE, noting that items that were not personally relevant were still important to ask. Overall, participants found the AE-QoL comprehensible and comprehensive, although some participants, primarily adolescents, reported being unfamiliar with the word "leisure," making it difficult to answer the item asking about impact of attacks on "leisure time." Adolescents also reported that questions about school-related impacts were missing and would be important to ask about specifically.

CONCLUSIONS

This study presents evidence that supports the content validity of the AE-QoL in adult and adolescent patients with HAE. While revisions could be considered prior to using the instrument with samples of adolescent patients with HAE, in general, adolescents and adults with HAE found the measure relevant, comprehensive, and comprehensible.

摘要

背景

缺乏明确证据表明存在一种适用于测量遗传性血管性水肿(HAE)成年和青少年患者健康相关生活质量(HRQoL)影响的适用工具。本研究的目的是确定血管性水肿生活质量问卷(AE-QoL)在内容上是否有效,以及是否适合用于捕捉HAE发作对成年和青少年HAE患者HRQoL的影响。

方法

本研究采用一对一、录音的认知反馈访谈,运用出声思考和言语探查方法,评估AE-QoL在该患者群体中的相关性、可理解性和全面性。所有数据经过质量检查后,使用归纳和演绎方法进行编码和分析。

结果

本研究纳入了美国10名青少年和12名成年HAE患者。总体而言,参与者对AE-QoL有积极印象,认为问卷长度和回忆期合适,回答选项清晰易懂。一些人报告对说明有轻微担忧,但都不妨碍他们完成该问卷。参与者发现该问卷与他们的HAE经历相关,并指出一些与个人无关的问题仍然值得询问。总体而言,参与者认为AE-QoL易于理解且全面,不过一些参与者,主要是青少年,报告不熟悉“休闲”一词,这使得他们难以回答关于发作对“休闲时间”影响的问题。青少年还报告说缺少关于学校相关影响的问题,专门询问这些问题会很重要。

结论

本研究提供的证据支持AE-QoL在成年和青少年HAE患者中的内容效度。虽然在将该问卷用于青少年HAE患者样本之前可以考虑进行修订,但总体而言,成年和青少年HAE患者认为该测量方法相关、全面且易于理解。

相似文献

1
Content validation of the Angioedema Quality of Life Questionnaire (AE-QoL) in a population of adult and adolescent patients with hereditary angioedema (HAE).遗传性血管性水肿(HAE)成年和青少年患者群体中血管性水肿生活质量问卷(AE-QoL)的内容效度验证。
J Patient Rep Outcomes. 2025 Apr 12;9(1):42. doi: 10.1186/s41687-025-00876-3.
2
Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.遗传性血管性水肿生活质量问卷的内容验证和心理计量学评估
J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.
3
Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency.一种用于C1抑制剂缺乏所致遗传性血管性水肿的美国生活质量评估工具的开发与验证
Ann Allergy Asthma Immunol. 2024 Dec;133(6):703-711.e6. doi: 10.1016/j.anai.2024.07.018. Epub 2024 Jul 20.
4
Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.通过患者报告结局分析日本遗传性血管性水肿患者的疾病负担
J Dermatol. 2025 Feb;52(2):256-269. doi: 10.1111/1346-8138.17421. Epub 2024 Sep 11.
5
Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.用于观察性研究中遗传性血管性水肿评估的患者报告结局问卷的开发与内容效度测试
Health Qual Life Outcomes. 2015 Jul 1;13:92. doi: 10.1186/s12955-015-0292-7.
6
A COSMIN systematic review of instruments for evaluating health-related quality of life in people with Hereditary Angioedema.一项关于评估遗传性血管性水肿患者健康相关生活质量的工具的COSMIN系统评价。
Health Qual Life Outcomes. 2025 Feb 13;23(1):12. doi: 10.1186/s12955-025-02342-6.
7
Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study.评估成人遗传性血管性水肿急性发作症状严重程度的视觉模拟评分的内容效度:一项访谈研究。
Patient. 2012;5(2):113-26. doi: 10.2165/11597490-000000000-00000.
8
Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.瑞典遗传性血管性水肿成年患者的健康相关生活质量与疾病活动的关系
Allergy Asthma Proc. 2017 Nov 30;38(6):447-455. doi: 10.2500/aap.2017.38.4087. Epub 2017 Aug 30.
9
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.遗传性血管性水肿患者生活质量问卷的制定:西班牙多中心研究项目(HAE-QoL)。
Health Qual Life Outcomes. 2012 Jul 20;10:82. doi: 10.1186/1477-7525-10-82.
10
Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.遗传性血管性水肿成人生活质量问卷的心理测量学现场研究:HAE-QoL。
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):464-473.e4. doi: 10.1016/j.jaip.2015.12.010. Epub 2016 Mar 8.

引用本文的文献

1
Impact of hereditary angioedema attacks on health-related quality of life and work productivity.遗传性血管性水肿发作对健康相关生活质量和工作生产力的影响。
World Allergy Organ J. 2025 Jul 28;18(8):101083. doi: 10.1016/j.waojou.2025.101083. eCollection 2025 Aug.

本文引用的文献

1
Efficacy and Safety of Donidalorsen for Hereditary Angioedema.Donidalorsen 治疗遗传性血管性水肿的疗效和安全性。
N Engl J Med. 2024 Jul 4;391(1):21-31. doi: 10.1056/NEJMoa2402478. Epub 2024 May 31.
2
An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments.对美国食品药品监督管理局就《以患者为中心的药物研发指南3:选择、开发或修改适用的临床结局评估》草案的访谈
Value Health. 2023 Jun;26(6):791-795. doi: 10.1016/j.jval.2023.04.006. Epub 2023 Apr 26.
3
Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.遗传性血管性水肿生活质量问卷的内容验证和心理计量学评估
J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.
4
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.加拉西班单抗治疗遗传性血管性水肿预防的疗效和安全性(VANGUARD):一项全球、多中心、随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2023 Apr 1;401(10382):1079-1090. doi: 10.1016/S0140-6736(23)00350-1. Epub 2023 Feb 28.
5
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.《遗传性血管性水肿管理的国际 WAO/EAACI 指南-2021 年修订版》。
Allergy. 2022 Jul;77(7):1961-1990. doi: 10.1111/all.15214. Epub 2022 Feb 3.
6
Purposive sampling: complex or simple? Research case examples.立意抽样:复杂还是简单?研究案例
J Res Nurs. 2020 Dec;25(8):652-661. doi: 10.1177/1744987120927206. Epub 2020 Jun 18.
7
Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study.1型和2型遗传性血管性水肿的心理社会负担:一项加拿大单中心队列研究。
Allergy Asthma Clin Immunol. 2021 Jun 29;17(1):61. doi: 10.1186/s13223-021-00563-0.
8
Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy.倾听患者心声:一项基于深入定性研究的调查,探究皮下注射C1抑制剂替代疗法治疗的遗传性血管性水肿真实世界患者中与健康相关生活质量相关的因素。
Allergy Asthma Clin Immunol. 2021 Jun 27;17(1):60. doi: 10.1186/s13223-021-00550-5.
9
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report.遗传性血管性水肿患者疾病负担与生活质量的评估及管理:一份共识报告
Allergy Asthma Clin Immunol. 2021 Apr 19;17(1):40. doi: 10.1186/s13223-021-00537-2.
10
How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?血管性水肿生活质量问卷如何帮助医生治疗 C1 抑制剂缺乏症患者?
Clin Rev Allergy Immunol. 2021 Aug;61(1):50-59. doi: 10.1007/s12016-021-08850-9. Epub 2021 Mar 3.